Geron | GERN - Interest Expense On Debt


Geron reported $7.3M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Amgen USD 653M 32M Dec/2025
Bio Techne USD 2.18M 173K Jun/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Cytokinetics USD 30.33M 4.01M Dec/2025
Esperion Therapeutics USD 22.64M 585K Dec/2025
Exelixis USD 23.4M 3.9M Sep/2023
Genmab DKK 10M 27M Dec/2025
Geron USD 7.3M 1.35M Dec/2025
Gilead Sciences USD 255M 1000K Dec/2025
Incyte USD 582K 10K Dec/2025
MacroGenics USD 3.34M 2.54M Sep/2025
Novartis USD 304M 23M Dec/2025
Novavax USD 5.82M 342K Dec/2025